Search results for "GLIM"

showing 10 items of 23 documents

Latvijas Vēstures Institūta Žurnāls. 2012, Nr. 3 (84)

2012

:HUMANITIES and RELIGION::History and philosophy subjects::Archaeology subjects [Research Subject Categories]:HUMANITIES and RELIGION::History and philosophy subjects::History subjects [Research Subject Categories]A First Glimpse of the Organisation of Space in the Late Palaeolithic of LatviaRecenzijas1863. gada poļu sacelšanās notikumi LatgalēZinātnes dzīveVēstures avotiAgro jauno laiku konceptsPretošanās kustība nacionālsociālistiskās Vācijas okupētajā Latvijā 1941-1945Personālijas
researchProduct

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mel…

2005

The study was performed to investigate the effect of improving metabolic control with pioglitazone in comparison to glimepiride on microvascular function in patients with diabetes mellitus type 2.A total of 179 patients were recruited and randomly assigned to one treatment group. Metabolic control (HbA1c), insulin resistance (HOMA index), and microvascular function (laser Doppler fluxmetry) were observed at baseline and after 3 and 6 months.HbA1c improved in both treatment arms (pioglitazone: 7.52 +/- 0.85% to 6.71 +/- 0.89%, p.0001; glimepiride: 7.44 +/- 0.89% to 6.83 +/- 0.85%, p.0001). Insulin-resistance decreased significantly in the pioglitazone group (6.15 +/- 4.05 to 3.85 +/- 1.92, p…

AdultBlood GlucoseMalemedicine.medical_specialtyEndotheliumPhysiologyArbitrary unitInsulin resistancePhysiology (medical)Diabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsMolecular BiologyAgedPioglitazonebusiness.industryMicrocirculationGlucose clamp techniqueMiddle Agedmedicine.diseaseGlimepirideEndocrinologymedicine.anatomical_structureSulfonylurea CompoundsDiabetes Mellitus Type 2Metabolic control analysisGlucose Clamp TechniqueFemaleThiazolidinedionesEndothelium VascularInsulin ResistanceCardiology and Cardiovascular MedicinebusinessPioglitazoneBlood Flow Velocitymedicine.drugMicrocirculation (New York, N.Y. : 1994)
researchProduct

Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus

2010

The aim of the present study was to compare the effect of PIO (pioglitazone) or GLIM (glimepiride) on erythrocyte deformability in T2DM (Type 2 diabetes mellitus). The study covered 23 metformin-treated T2DM patients with an HbA1c (glycated haemoglobin) >6.5%. Patients were randomized to receive either PIO (15 mg, twice a day) or GLIM (1 mg, twice a day) in combination with metformin (850 mg, twice a day) for 6 months. Blood samples were taken for the measurement of fasting glucose, HbA1c, fasting insulin, intact proinsulin, adiponectin and Hct (haematocrit). In addition, the erythrocyte EI (elongation index) was measured using laser diffractoscopy. Both treatments significantly impr…

AdultMalemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentType 2 diabetesInsulin resistanceErythrocyte DeformabilityInternal medicineDiabetes mellitusHumansHypoglycemic AgentsMedicineAgedProinsulinGlycated HemoglobinPioglitazoneAdiponectinbusiness.industryInsulinnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseMetforminGlimepirideSulfonylurea CompoundsEndocrinologyDiabetes Mellitus Type 2Drug Therapy CombinationFemaleThiazolidinedionesStress MechanicalbusinessPioglitazonemedicine.drugClinical Science
researchProduct

Screening of pharmacologic adulterant classes in herbal formulations using voltammetry of microparticles.

2013

A solid state electrochemical method for screening different families of adulterant chemicals illegally added to commercial phytotherapuetic formulations is described. The proposed method, based on the voltammetry of microparticles approach, permits a fast and sensitive way to distinguish between anorexics (amfepramone, fenproporex, sibutramine), benzozodiazepinic anxiolytics (clonazepam, flurazepam, alprazolam, midazolam, medazepam, chlordiazepoxide, diazepam), antidepressants (bupropione, fluoxetine, sertraline, paroxetine), diuretics (hydrochlorothiazide, furosemide, chlortalidone, amiloride, spironolactone), and hypoglycemics (glimepiride, chlorpropamide, glibenclamide) based on charact…

AdulterantChromatographyFlurazepamChemistryChemistry PharmaceuticalClinical BiochemistryAmfepramoneDrug Evaluation PreclinicalPharmaceutical ScienceElectrochemical TechniquesPharmacologyFenproporexMicrospheresAnalytical ChemistryMedazepamGlimepirideHydrochlorothiazideDrug DiscoverymedicinePlant PreparationsDrug ContaminationDiazepamSpectroscopymedicine.drugJournal of pharmaceutical and biomedical analysis
researchProduct

Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus

2012

This study compared the effect of Glimepiride versus Vildagliptin on β-cell function and the release of intact proinsulin (PI) in patients with type 2 diabetes mellitus. Patients on metformin monotherapy were randomized to add on treatment with Vildagliptin or Glimepiride. A standardized test meal was given at baseline, after 12 and 24 weeks of treatment. Insulin, PI and blood glucose values were measured in the fasting state and postprandial for 300 min. Fasting PI levels significantly decreased in the Vildagliptin group. The area under the curve for the postprandial release of PI decreased during Vildagliptin and increased during Glimepiride treatment. The proinsulin to insulin ratio decl…

Blood GlucoseMalemedicine.medical_specialtyPyrrolidinesendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAdamantaneEndocrinologyDiabetes mellitusInternal medicineNitrilesInternal MedicinemedicineHumansHypoglycemic AgentsVildagliptinProinsulinVildagliptinDipeptidyl-Peptidase IV Inhibitorsbusiness.industryInsulinnutritional and metabolic diseasesType 2 Diabetes MellitusPostprandial Periodmedicine.diseaseMetforminMetforminGlimepirideSulfonylurea CompoundsTreatment OutcomePostprandialEndocrinologyDiabetes Mellitus Type 2Area Under CurveDrug Therapy CombinationFemalebusinessProinsulinmedicine.drugDiabetes, Obesity and Metabolism
researchProduct

Confisca per equivalente e proscioglimento

2019

Gli interventi contemplati nella legge 9 gennaio 2019, n. 3 intendono astrattamente raccogliere le numerose sollecitazioni internazionali verso la prevenzione e la repressione dei fenomeni corruttivi. Nel complesso la manovra normativa disvela la sempre più stretta connessione tra le norme anticorruzione e il modello differenziato di contrasto al crimine organizzato a causa delle caratteristiche endemiche e distorsive dei fenomeni corruttivi nel nostro Paese. L'analisi critica, condotta sui tre versanti: a) delle innovazioni in tema di affidamento dei beni mobili diversi dal danaro agli organi di polizia giudiziaria; b) dell'estensione della riparazione per equivalente già contemplata nell’…

ConfiscaProscioglimentoSettore IUS/16 - Diritto Processuale PenaleCorruzione
researchProduct

INCANDIDABILITÀ DEGLI AMMINISTRATORI EX ART. 143, COMMA 11, T.U.E.L. ALLA LUCE DELLE MODIFICHE INTRODOTTE DAL D.L. N. 113/2018 E DELLE PROPOSTE DI LE…

2019

L’art. 143 del d.Lgs. n. 267/2000 attribuisce al governo il potere di sciogliere i consigli comunali e provinciali in conseguenza di fenomeni di infiltrazione e condizionamento di tipo mafioso. Una delle conseguenze è l’incandidabilità temporanea degli amministratori “responsabili delle condotte che hanno dato causa allo scioglimento” del Consiglio dell’ente locale (art. 143, comma 11), dichiarata dal tribunale civile con procedimento in camera di consiglio (artt. 737 ss. c.p.c.). Lo scioglimento ex art. 143 costituisce una misura di carattere eccezionale e cautelare. Tale istituto, nato in uno dei momenti più difficili della lotta alla mafia, è stato, sin da subito, oggetto di dibattito in…

Incandidabilità Scioglimento Mafia
researchProduct

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately …

2017

Background The best treatment option for patients with type 2 diabetes in whom treatment with metformin alone fails to achieve adequate glycaemic control is debated. We aimed to compare the long-term effects of pioglitazone versus sulfonylureas, given in addition to metformin, on cardiovascular events in patients with type 2 diabetes. Methods TOSCA.IT was a multicentre, randomised, pragmatic clinical trial, in which patients aged 50–75 years with type 2 diabetes inadequately controlled with metformin monotherapy (2–3 g per day) were recruited from 57 diabetes clinics in Italy. Patients were randomly assigned (1:1), by permuted blocks randomisation (block size 10), stratified by site and…

MaleDiabetes and Metabolism ipoglycemic drugs cardiovascualr eventSettore MED/09 - Medicina Internaendocrine system diseasesIMPACTpioglitazone versus sulfonylureasEndocrinology Diabetes and MetabolismGLIMEPIRIDEDiabetes cardiovascular events metformin pioglitazone sulphonylureasType 2 diabetes030204 cardiovascular system & hematologyInternal Medicine; Endocrinology Diabetes and Metabolism; Endocrinologylaw.inventionSettore MED/13 - EndocrinologiaGlibenclamide0302 clinical medicineRandomized controlled triallawGLYCEMIC CONTROLGliclazideInternal medicinediabetes and metabolismRISKeducation.field_of_studydiabetesIncidenceInternal medicine; endocrinology diabetes and metabolism; endocrinologyMiddle AgedINSULINMetforminMetforminTreatment OutcomeEditorialsulphonylureasCardiovascular DiseasesCombinationDrug Therapy CombinationFemaleType 2medicine.drugmedicine.medical_specialtyPopulation030209 endocrinology & metabolismAged; Cardiovascular Diseases; Diabetes Mellitus Type 2; Drug Therapy Combination; Female; Humans; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Pioglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment OutcomeCardiovascular events03 medical and health sciencesendocrinologyGLUCOSE-LOWERING DRUGSDrug TherapyInternal medicineDiabetes MellitusmedicineHumansHypoglycemic AgentssulfonylureaseducationTOSCA.ITAgedPioglitazonebusiness.industryMORTALITYnutritional and metabolic diseasesInsulin resistancemedicine.diseaseSurgeryGlimepirideSulfonylurea CompoundsDiabetes Mellitus Type 2Diabetes Mellitus; Pioglitazone; Insulin resistanceThiazolidinedionesbusinessFOLLOW-UPPioglitazone
researchProduct

Spatial Interaction between Neighbouring Counties: Cancer Mortality Data in Valencia (Spain)

1995

The statistical analysis of geographical mortality data has usually been approached via regression models that include appropriate covariates. These models assume stochastic independence of mortality counts for neighbouring sites, a questionable assumption that spatial automodels (Besag, 1974, Journal of the Royal Statistical Society, Series B 36, 192-236) make unnecessary. This paper presents the use of the autopoisson distribution in order to detect spatial interaction between neighbouring sites. If this interaction results in being nonsignificant, the auto-Poisson distribution reduces to a usual Poisson regression model, a particular case of generalized linear models (McCullagh and Nelde…

MaleStatistics and ProbabilityGeneralized linear modelGLIMPoisson distributionGeneral Biochemistry Genetics and Molecular Biologysymbols.namesakeStomach NeoplasmsNeoplasmsStatisticsCovariateHumansPoisson DistributionPoisson regressionFertilizersDemographyCancer mortalityModels StatisticalNitratesGeneral Immunology and MicrobiologyApplied MathematicsSpatial interactionProstatic NeoplasmsRegression analysisGeneral MedicineGeographyUrinary Bladder NeoplasmsSpainColonic NeoplasmssymbolsRegression AnalysisGeneral Agricultural and Biological SciencesDemographyBiometrics
researchProduct

Imeglimin Normalizes Glucose Tolerance and Insulin Sensitivity and Improves Mitochondrial Function in Liver of a High-Fat, High-Sucrose Diet Mice Mod…

2015

International audience; Imeglimin is the first in a new class of oral glucose-lowering agents currently in phase 2b development. Although imeglimin improves insulin sensitivity in humans, the molecular mechanisms are unknown. This study used a model of 16-week high-fat, high-sucrose diet (HFHSD) mice to characterize its antidiabetic effects. Six-week imeglimin treatment significantly decreased glycemia, restored normal glucose tolerance, and improved insulin sensitivity without modifying organs, body weights, and food intake. This was associated with an increase in insulin-stimulated protein kinase B phosphorylation in the liver and muscle. In liver mitochondria, imeglimin redirects substra…

Malemedicine.medical_specialtyMale Animals Mice Inbred C57BL Insulin Resistance/*physiology Diet High-Fat/adverse effects Hypoglycemic Agents/*therapeutic use Liver/*drug effects/*metabolism Mitochondria/*drug effects/*metabolism Triazines/*therapeutic useImegliminMitochondria/*drug effects/*metabolismEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]High-Fat/adverse effectsBiologyMitochondrionDiet High-Fatmedicine.disease_causeInbred C57BLchemistry.chemical_compoundMiceLipid oxidationInternal medicineInternal MedicinemedicineHypoglycemic Agents/*therapeutic useHypoglycemic AgentsAnimalsProtein kinase BBeta oxidationComputingMilieux_MISCELLANEOUS2. Zero hungerchemistry.chemical_classificationReactive oxygen speciesTriazines/*therapeutic useTriazinesMitochondria3. Good healthDietMice Inbred C57BL[SDV] Life Sciences [q-bio]EndocrinologyLiver/*drug effects/*metabolismLiverchemistryInsulin Resistance/*physiologyCoenzyme Q – cytochrome c reductaseInsulin ResistanceOxidative stress
researchProduct